Clene financials
$4.10+0.99%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $200.0K | $342.0K | $654.0K | $473.0K | $723.0K | $206.0K |
| Gross profit | $157.0K | $272.0K | $533.0K | $447.0K | $434.0K | $141.0K |
| Gross margin | 78.5% | 79.5% | 81.5% | 94.5% | 60.0% | 68.4% |
| Operating income | -$23.1M | -$33.1M | -$40.5M | -$48.4M | -$50.0M | -$20.2M |
| Net income | -$26.2M | -$39.4M | -$49.5M | -$29.9M | -$9.7M | -$19.3M |
| Net margin | −13086.5% | −11520.5% | −7569.4% | −6325.2% | −1347.2% | −9357.8% |
| Diluted EPS | $-2.65 | $-5.67 | $-9.43 | $-9.20 | $-3.20 | $-22.00 |
| EBITDA | -$21.6M | -$31.4M | -$38.8M | -$47.0M | -$48.9M | -$19.3M |
| Operating cash flow | -$18.5M | -$21.3M | -$30.2M | -$39.0M | -$34.6M | -$18.9M |
| Free cash flow | -$18.6M | -$21.3M | -$30.5M | -$44.2M | -$36.0M | -$19.3M |
| Diluted shares | 9.9M | 7.0M | 5.2M | 3.3M | 3.1M | 0.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.2M | $12.2M | $28.8M | $18.3M | $50.3M | $59.3M |
| Short-term investments | $0.00 | $0.00 | $6.2M | $5.0M | $0.00 | — |
| Total debt | $17.6M | $15.8M | $26.7M | $25.8M | $19.3M | $2.3M |
| Total assets | $18.1M | $27.3M | $52.3M | $44.5M | $63.1M | $68.2M |
| Total liabilities | $35.7M | $36.2M | $39.0M | $41.3M | $50.5M | $67.9M |
| Shareholders' equity | -$17.6M | -$8.9M | $13.4M | $3.2M | $12.6M | $341.0K |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology